Financial Comparison: ReWalk Robotics (NASDAQ:LFWD) & Ortho Regenerative Technologies (OTCMKTS:ORTIF)
ReWalk Robotics (NASDAQ:LFWD – Get Free Report) and Ortho Regenerative Technologies (OTCMKTS:ORTIF – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for ReWalk Robotics and Ortho Regenerative Technologies, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| ReWalk Robotics | 0 | 0 | 1 | 0 | 3.00 |
| Ortho Regenerative Technologies | 0 | 0 | 0 | 0 | N/A |
ReWalk Robotics currently has a consensus price target of $13.00, indicating a potential upside of 159.48%. Given ReWalk Robotics’ higher probable upside, research analysts clearly believe ReWalk Robotics is more favorable than Ortho Regenerative Technologies.
Volatility & Risk
ReWalk Robotics has a beta of 2.06, indicating that its share price is 106% more volatile than the S&P 500. Comparatively, Ortho Regenerative Technologies has a beta of -1.16, indicating that its share price is 216% less volatile than the S&P 500.
Profitability
This table compares ReWalk Robotics and Ortho Regenerative Technologies’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| ReWalk Robotics | -134.52% | -35.41% | -27.64% |
| Ortho Regenerative Technologies | N/A | N/A | -269.68% |
Valuation and Earnings
This table compares ReWalk Robotics and Ortho Regenerative Technologies’ revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| ReWalk Robotics | $13.85 million | 3.11 | -$22.13 million | ($3.11) | -1.61 |
| Ortho Regenerative Technologies | N/A | N/A | -$3.93 million | ($0.11) | -1.78 |
Ortho Regenerative Technologies has lower revenue, but higher earnings than ReWalk Robotics. Ortho Regenerative Technologies is trading at a lower price-to-earnings ratio than ReWalk Robotics, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
26.8% of ReWalk Robotics shares are owned by institutional investors. 2.1% of ReWalk Robotics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Summary
ReWalk Robotics beats Ortho Regenerative Technologies on 8 of the 12 factors compared between the two stocks.
About ReWalk Robotics
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.
About Ortho Regenerative Technologies
Ortho Regenerative Technologies Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and Ortho-V, a biopolymer for osteoarthritis healing, as well as ORTHO-T, a biopolymer formulation for tendon healing and regeneration. The company was incorporated in 2015 and is headquartered in Kirkland, Canada.
Receive News & Ratings for ReWalk Robotics Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for ReWalk Robotics and related companies with MarketBeat.com’s FREE daily email newsletter.
